Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus
Esophageal adenocarcinoma is increasing in incidence and has a high mortality unless detected early. Barrett's esophagus is the only known risk factor for this cancer; however, whether endoscopic surveillance reduces morbidity and mortality is controversial. Endoscopic cancer surveillance progr...
Gespeichert in:
Veröffentlicht in: | Digestive diseases and sciences 2001-09, Vol.46 (9), p.1892-1898 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1898 |
---|---|
container_issue | 9 |
container_start_page | 1892 |
container_title | Digestive diseases and sciences |
container_volume | 46 |
creator | FITZGERALD, Rebecca C SAEED, Ibtisan T KHOO, David FARTHING, Michael J. G BURNHAM, W. Rodney |
description | Esophageal adenocarcinoma is increasing in incidence and has a high mortality unless detected early. Barrett's esophagus is the only known risk factor for this cancer; however, whether endoscopic surveillance reduces morbidity and mortality is controversial. Endoscopic cancer surveillance programes for Barrett's esophagus are not routinely practiced in the UK, and this is the first study to examine whether a rigorous surveillance protocol increases the detection rate of early oesophageal cancer. All patients with a diagnosis of Barrett's esophagus or associated adenocarcinoma attending Havering Hospitals NHS Trust between 1992 and 1998 were included. A retrospective analysis was made of patients undergoing informal surveillance (96 patients, 1992-1997) and a prospective analysis was conducted following the implementation of a rigorous protocol (108 patients, 1997-1998). Over the same time periods Barrett's associated cancers diagnosed in patients not undergoing surveillance were analyzed (262 patients 1992-1997, 98 patients 1997-1998). From 1992 to 1997, one case of high-grade dysplasia was detected (N = 96, 1%). From 1997 to 1998, two cancers and three high-grade dysplasias were detected during rigorous surveillance (N = 108, 4.6%). Three of these patients have had curative esophagectomies (one high-grade dysplasia and two T1,N0,M0 tumors). In 1992-1997, 10 patients were found to have cancer in previously undiagnosed Barrett's esophagus (N = 262, 3.8%). Of 3/10 cancers treated surgically, one patient had a curative procedure (T1,N0,M0). In 1997-1998, nine patients were found to have de novo Barrett's esophagus cancer (N = 88, 10.2%) and three had curative resections (T1,N0,M0). Two of the patients with T1 lesions had no endoscopic evidence of cancer but were detected as a result of the multiple biopsy protocol. In conclusion, a rigorous biopsy protocol increases the detection of early cancer in Barrett's esophagus. |
doi_str_mv | 10.1023/A:1010678913481 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71195666</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71195666</sourcerecordid><originalsourceid>FETCH-LOGICAL-c310t-6c0d30c15f51f693b030f3977a58f1e4c4c8e76dd3a82a24dba0f27c0d74907c3</originalsourceid><addsrcrecordid>eNpd0E1LJDEQBuAgLjq6nr1JENTTaCpJJ93e3MGPBWFB1nOTSVdrpGcyptLK_vvN4IjgqerwVFFvMXYI4hyEVBdXlyBAGFs3oHQNW2wClVVTWZl6m00EmNIDmF22R_QihGgsmB22C0VVWsOEhYfwFFMcidOY3jAMg1t65KsUc_Rx4GHpEzpC4h1m9DnEJY8992Ny8wG5X-tE3BFFH1zGjr-H_Mx_uZQw5zPiSHH17J5G-sl-9G4gPNjUffZ4c_13dje9_3P7e3Z1P_UKRJ4aLzolPFR9Bb1p1Fwo0avGWlfVPaD22tdoTdcpV0sndTd3ope2TFndCOvVPjv92FsyvI5IuV0E8rgOhiVnawGayhhT4PE3-BLHtCy3tRK0krW1dUFHGzTOF9i1qxQWLv1rPz9YwMkGOPJu6FP5SKAvp0FLC1L9B08ZgJs</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>214328778</pqid></control><display><type>article</type><title>Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>FITZGERALD, Rebecca C ; SAEED, Ibtisan T ; KHOO, David ; FARTHING, Michael J. G ; BURNHAM, W. Rodney</creator><creatorcontrib>FITZGERALD, Rebecca C ; SAEED, Ibtisan T ; KHOO, David ; FARTHING, Michael J. G ; BURNHAM, W. Rodney</creatorcontrib><description>Esophageal adenocarcinoma is increasing in incidence and has a high mortality unless detected early. Barrett's esophagus is the only known risk factor for this cancer; however, whether endoscopic surveillance reduces morbidity and mortality is controversial. Endoscopic cancer surveillance programes for Barrett's esophagus are not routinely practiced in the UK, and this is the first study to examine whether a rigorous surveillance protocol increases the detection rate of early oesophageal cancer. All patients with a diagnosis of Barrett's esophagus or associated adenocarcinoma attending Havering Hospitals NHS Trust between 1992 and 1998 were included. A retrospective analysis was made of patients undergoing informal surveillance (96 patients, 1992-1997) and a prospective analysis was conducted following the implementation of a rigorous protocol (108 patients, 1997-1998). Over the same time periods Barrett's associated cancers diagnosed in patients not undergoing surveillance were analyzed (262 patients 1992-1997, 98 patients 1997-1998). From 1992 to 1997, one case of high-grade dysplasia was detected (N = 96, 1%). From 1997 to 1998, two cancers and three high-grade dysplasias were detected during rigorous surveillance (N = 108, 4.6%). Three of these patients have had curative esophagectomies (one high-grade dysplasia and two T1,N0,M0 tumors). In 1992-1997, 10 patients were found to have cancer in previously undiagnosed Barrett's esophagus (N = 262, 3.8%). Of 3/10 cancers treated surgically, one patient had a curative procedure (T1,N0,M0). In 1997-1998, nine patients were found to have de novo Barrett's esophagus cancer (N = 88, 10.2%) and three had curative resections (T1,N0,M0). Two of the patients with T1 lesions had no endoscopic evidence of cancer but were detected as a result of the multiple biopsy protocol. In conclusion, a rigorous biopsy protocol increases the detection of early cancer in Barrett's esophagus.</description><identifier>ISSN: 0163-2116</identifier><identifier>EISSN: 1573-2568</identifier><identifier>DOI: 10.1023/A:1010678913481</identifier><identifier>PMID: 11575441</identifier><identifier>CODEN: DDSCDJ</identifier><language>eng</language><publisher>Heidelberg: Springer</publisher><subject>Adenocarcinoma - etiology ; Adenocarcinoma - prevention & control ; Adult ; Aged ; Aged, 80 and over ; Barrett Esophagus - complications ; Biological and medical sciences ; Cost-Benefit Analysis ; Esophageal Neoplasms - etiology ; Esophageal Neoplasms - prevention & control ; Esophagoscopy ; Esophagus ; Female ; Gastroenterology. Liver. Pancreas. Abdomen ; Humans ; Male ; Mass Screening - economics ; Mass Screening - methods ; Medical sciences ; Middle Aged ; Prospective Studies ; Retrospective Studies ; Tumors</subject><ispartof>Digestive diseases and sciences, 2001-09, Vol.46 (9), p.1892-1898</ispartof><rights>2002 INIST-CNRS</rights><rights>Copyright Kluwer Academic Publishers Sep 2001</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c310t-6c0d30c15f51f693b030f3977a58f1e4c4c8e76dd3a82a24dba0f27c0d74907c3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=14142712$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11575441$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>FITZGERALD, Rebecca C</creatorcontrib><creatorcontrib>SAEED, Ibtisan T</creatorcontrib><creatorcontrib>KHOO, David</creatorcontrib><creatorcontrib>FARTHING, Michael J. G</creatorcontrib><creatorcontrib>BURNHAM, W. Rodney</creatorcontrib><title>Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus</title><title>Digestive diseases and sciences</title><addtitle>Dig Dis Sci</addtitle><description>Esophageal adenocarcinoma is increasing in incidence and has a high mortality unless detected early. Barrett's esophagus is the only known risk factor for this cancer; however, whether endoscopic surveillance reduces morbidity and mortality is controversial. Endoscopic cancer surveillance programes for Barrett's esophagus are not routinely practiced in the UK, and this is the first study to examine whether a rigorous surveillance protocol increases the detection rate of early oesophageal cancer. All patients with a diagnosis of Barrett's esophagus or associated adenocarcinoma attending Havering Hospitals NHS Trust between 1992 and 1998 were included. A retrospective analysis was made of patients undergoing informal surveillance (96 patients, 1992-1997) and a prospective analysis was conducted following the implementation of a rigorous protocol (108 patients, 1997-1998). Over the same time periods Barrett's associated cancers diagnosed in patients not undergoing surveillance were analyzed (262 patients 1992-1997, 98 patients 1997-1998). From 1992 to 1997, one case of high-grade dysplasia was detected (N = 96, 1%). From 1997 to 1998, two cancers and three high-grade dysplasias were detected during rigorous surveillance (N = 108, 4.6%). Three of these patients have had curative esophagectomies (one high-grade dysplasia and two T1,N0,M0 tumors). In 1992-1997, 10 patients were found to have cancer in previously undiagnosed Barrett's esophagus (N = 262, 3.8%). Of 3/10 cancers treated surgically, one patient had a curative procedure (T1,N0,M0). In 1997-1998, nine patients were found to have de novo Barrett's esophagus cancer (N = 88, 10.2%) and three had curative resections (T1,N0,M0). Two of the patients with T1 lesions had no endoscopic evidence of cancer but were detected as a result of the multiple biopsy protocol. In conclusion, a rigorous biopsy protocol increases the detection of early cancer in Barrett's esophagus.</description><subject>Adenocarcinoma - etiology</subject><subject>Adenocarcinoma - prevention & control</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Barrett Esophagus - complications</subject><subject>Biological and medical sciences</subject><subject>Cost-Benefit Analysis</subject><subject>Esophageal Neoplasms - etiology</subject><subject>Esophageal Neoplasms - prevention & control</subject><subject>Esophagoscopy</subject><subject>Esophagus</subject><subject>Female</subject><subject>Gastroenterology. Liver. Pancreas. Abdomen</subject><subject>Humans</subject><subject>Male</subject><subject>Mass Screening - economics</subject><subject>Mass Screening - methods</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Prospective Studies</subject><subject>Retrospective Studies</subject><subject>Tumors</subject><issn>0163-2116</issn><issn>1573-2568</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>BENPR</sourceid><recordid>eNpd0E1LJDEQBuAgLjq6nr1JENTTaCpJJ93e3MGPBWFB1nOTSVdrpGcyptLK_vvN4IjgqerwVFFvMXYI4hyEVBdXlyBAGFs3oHQNW2wClVVTWZl6m00EmNIDmF22R_QihGgsmB22C0VVWsOEhYfwFFMcidOY3jAMg1t65KsUc_Rx4GHpEzpC4h1m9DnEJY8992Ny8wG5X-tE3BFFH1zGjr-H_Mx_uZQw5zPiSHH17J5G-sl-9G4gPNjUffZ4c_13dje9_3P7e3Z1P_UKRJ4aLzolPFR9Bb1p1Fwo0avGWlfVPaD22tdoTdcpV0sndTd3ope2TFndCOvVPjv92FsyvI5IuV0E8rgOhiVnawGayhhT4PE3-BLHtCy3tRK0krW1dUFHGzTOF9i1qxQWLv1rPz9YwMkGOPJu6FP5SKAvp0FLC1L9B08ZgJs</recordid><startdate>20010901</startdate><enddate>20010901</enddate><creator>FITZGERALD, Rebecca C</creator><creator>SAEED, Ibtisan T</creator><creator>KHOO, David</creator><creator>FARTHING, Michael J. G</creator><creator>BURNHAM, W. Rodney</creator><general>Springer</general><general>Springer Nature B.V</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20010901</creationdate><title>Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus</title><author>FITZGERALD, Rebecca C ; SAEED, Ibtisan T ; KHOO, David ; FARTHING, Michael J. G ; BURNHAM, W. Rodney</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c310t-6c0d30c15f51f693b030f3977a58f1e4c4c8e76dd3a82a24dba0f27c0d74907c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Adenocarcinoma - etiology</topic><topic>Adenocarcinoma - prevention & control</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Barrett Esophagus - complications</topic><topic>Biological and medical sciences</topic><topic>Cost-Benefit Analysis</topic><topic>Esophageal Neoplasms - etiology</topic><topic>Esophageal Neoplasms - prevention & control</topic><topic>Esophagoscopy</topic><topic>Esophagus</topic><topic>Female</topic><topic>Gastroenterology. Liver. Pancreas. Abdomen</topic><topic>Humans</topic><topic>Male</topic><topic>Mass Screening - economics</topic><topic>Mass Screening - methods</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Prospective Studies</topic><topic>Retrospective Studies</topic><topic>Tumors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>FITZGERALD, Rebecca C</creatorcontrib><creatorcontrib>SAEED, Ibtisan T</creatorcontrib><creatorcontrib>KHOO, David</creatorcontrib><creatorcontrib>FARTHING, Michael J. G</creatorcontrib><creatorcontrib>BURNHAM, W. Rodney</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Digestive diseases and sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>FITZGERALD, Rebecca C</au><au>SAEED, Ibtisan T</au><au>KHOO, David</au><au>FARTHING, Michael J. G</au><au>BURNHAM, W. Rodney</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus</atitle><jtitle>Digestive diseases and sciences</jtitle><addtitle>Dig Dis Sci</addtitle><date>2001-09-01</date><risdate>2001</risdate><volume>46</volume><issue>9</issue><spage>1892</spage><epage>1898</epage><pages>1892-1898</pages><issn>0163-2116</issn><eissn>1573-2568</eissn><coden>DDSCDJ</coden><abstract>Esophageal adenocarcinoma is increasing in incidence and has a high mortality unless detected early. Barrett's esophagus is the only known risk factor for this cancer; however, whether endoscopic surveillance reduces morbidity and mortality is controversial. Endoscopic cancer surveillance programes for Barrett's esophagus are not routinely practiced in the UK, and this is the first study to examine whether a rigorous surveillance protocol increases the detection rate of early oesophageal cancer. All patients with a diagnosis of Barrett's esophagus or associated adenocarcinoma attending Havering Hospitals NHS Trust between 1992 and 1998 were included. A retrospective analysis was made of patients undergoing informal surveillance (96 patients, 1992-1997) and a prospective analysis was conducted following the implementation of a rigorous protocol (108 patients, 1997-1998). Over the same time periods Barrett's associated cancers diagnosed in patients not undergoing surveillance were analyzed (262 patients 1992-1997, 98 patients 1997-1998). From 1992 to 1997, one case of high-grade dysplasia was detected (N = 96, 1%). From 1997 to 1998, two cancers and three high-grade dysplasias were detected during rigorous surveillance (N = 108, 4.6%). Three of these patients have had curative esophagectomies (one high-grade dysplasia and two T1,N0,M0 tumors). In 1992-1997, 10 patients were found to have cancer in previously undiagnosed Barrett's esophagus (N = 262, 3.8%). Of 3/10 cancers treated surgically, one patient had a curative procedure (T1,N0,M0). In 1997-1998, nine patients were found to have de novo Barrett's esophagus cancer (N = 88, 10.2%) and three had curative resections (T1,N0,M0). Two of the patients with T1 lesions had no endoscopic evidence of cancer but were detected as a result of the multiple biopsy protocol. In conclusion, a rigorous biopsy protocol increases the detection of early cancer in Barrett's esophagus.</abstract><cop>Heidelberg</cop><pub>Springer</pub><pmid>11575441</pmid><doi>10.1023/A:1010678913481</doi><tpages>7</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0163-2116 |
ispartof | Digestive diseases and sciences, 2001-09, Vol.46 (9), p.1892-1898 |
issn | 0163-2116 1573-2568 |
language | eng |
recordid | cdi_proquest_miscellaneous_71195666 |
source | MEDLINE; SpringerLink Journals |
subjects | Adenocarcinoma - etiology Adenocarcinoma - prevention & control Adult Aged Aged, 80 and over Barrett Esophagus - complications Biological and medical sciences Cost-Benefit Analysis Esophageal Neoplasms - etiology Esophageal Neoplasms - prevention & control Esophagoscopy Esophagus Female Gastroenterology. Liver. Pancreas. Abdomen Humans Male Mass Screening - economics Mass Screening - methods Medical sciences Middle Aged Prospective Studies Retrospective Studies Tumors |
title | Rigorous surveillance protocol increases detection of curable cancers associated with Barrett's esophagus |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-16T01%3A05%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Rigorous%20surveillance%20protocol%20increases%20detection%20of%20curable%20cancers%20associated%20with%20Barrett's%20esophagus&rft.jtitle=Digestive%20diseases%20and%20sciences&rft.au=FITZGERALD,%20Rebecca%20C&rft.date=2001-09-01&rft.volume=46&rft.issue=9&rft.spage=1892&rft.epage=1898&rft.pages=1892-1898&rft.issn=0163-2116&rft.eissn=1573-2568&rft.coden=DDSCDJ&rft_id=info:doi/10.1023/A:1010678913481&rft_dat=%3Cproquest_pubme%3E71195666%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=214328778&rft_id=info:pmid/11575441&rfr_iscdi=true |